Lakefront Biotherapeutics ( GLPGF) - Stock Earnings
GLPGF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 917.9 million USD | 1.1 billion USD |
| 2026Q1 | 16.7 million USD | 7.5 million USD |
| 2026Q2 | 2.4 million USD | 13.8 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
GLPGF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 234.0 million USD | 265.0 million USD |
| 2024 | 77.1 million USD | 287.0 million USD |
| 2025 | 376.6 million USD | 1.3 billion USD |
| 2026 Est. | — | — |
GLPGF
Price: $26.24
52 week price:
Earnings Per Share: 10.40 USD
P/E Ratio: 4.68
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.2 billion